✦ LIBER ✦

Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment

✍ Scribed by Maas, K.W.; van der Lee, I.; Bolt, K.; Zanen, P.; Lammers, J.W.J.; Schramel, F.M.N.H.

Book ID: 118571176
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 211 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)00237-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the paclitaxel–cisplatin

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Combination of low-dose cisplatin and ge

Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

✍ J. Feliu; G. Martín; C. Madroñal; A. Rodríguez-Jaráiz; J. Castro; A Rodríguez; T 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

Post-chemotherapy gross tumor volume is

Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy

✍ Stinchcombe, Thomas E.; Morris, David E.; Moore, Dominic T.; Bechtel, John H.; H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Pulmonary function changes after inducti

Pulmonary function changes after induction chemotherapy with cisplatinum and gemcitabine in stage III non small cell lung cancer. Any additional risk for surgery?

✍ Leo, F; Solli, P; Veronesi, G; D'Aiuto, M; Ratcliffe, C; D'Ovidio, F; Pastorino, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 209 KB

O-95 Combined modality therapy in a popu

O-95 Combined modality therapy in a population-based cohort of patients with stage III Non-small cell lung cancer

✍ Wai, Elaine S.; Moravan, Veronika; Truong, Pauline; Berthelet, Eric; Lim, Jan T. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

The value of combined-modality therapy i

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l